Photodynamic Therapy Market accounted for over US$ 900 million in 2019. The market is anticipated to grow at a CAGR of 16.6% from 2019 to 2030.
The market growth can be attributed to several factors, which have led to its wide-scale adoption. The increasing prevalence of skin disorders & cancers and the approval of new biologics for photodynamic therapy are anticipated to further contribute to this substantial market growth during the forecast period. However, risks and side effects associated with the therapy are likely to restrain market growth to a certain extent.
Top Players:
Some of the prominent players in the photodynamic therapy market include Sun Pharmaceutical Industries Ltd., BIOFRONTERA AG, Theralase Technologies Inc., LUMIBIRD, Quest PharmaTech Inc., Modulight, Inc., Galderma, Suslaser.com, Biolitec AG, and Bausch & Lomb, among others.
No comments:
Post a Comment